SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
3,433,933
Share change
-156,740
Total reported value
$57,743,000
Price per share
$16.84
Number of holders
35
Value change
-$933,211
Number of buys
17
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q3 2017

As of 30 Sep 2017, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,433,933 shares. The largest 10 holders included BVF INC/IL, BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., PARSONS CAPITAL MANAGEMENT INC/RI, RTW INVESTMENTS, LP, AXA, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., Morse Asset Management, Inc, and Sectoral Asset Management Inc. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.